Markets

Health Care Sector Update for 02/17/2017: MYGN

Top Health-care stocks:

JNJ: flat

PFE: -0.5%

ABT: +1.6%

MRK: +0.3%

AMGN: -1.1%

Health-care shares were mixed in pre-market trade Friday.

In health-care stocks news, Myriad Genetics ( MYGN ) said Friday that a study shows that its BRACAnalysis CDx test successfully identified patients with HER2-negative metastatic breast cancer who have BRCA mutations and who had improved response with Lynparza, AstraZeneca's ( AZN ) PARP inhibitor.

Shares in the company were 0.1% lower at $17.25 pre-bell. The stock has traded between $15.15 and $39.74 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MYGN AZN

Other Topics

US Markets

Latest Markets Videos